Atlas Trials

Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH)

Clinical trial NCT04857840 · TERMINATED

Trial details

NCT number
NCT04857840
Sponsor
Quantum Genomics SA
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypertension (HTN)
Start date
2021-08-05
Primary completion
2023-01-09
Enrollment
419

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.